Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Utilization of Genomic Signature as Decision-making for Adjuvant Treatment of Breast Cancer (SA02)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2013 by Institut Paoli-Calmettes.
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Institut Paoli-Calmettes
ClinicalTrials.gov Identifier:
NCT00912080
First received: May 29, 2009
Last updated: March 19, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)